These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8369042)

  • 21. NIH Consensus 1994: screening.
    Kramer BS; Gohagan J; Prorok PC
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S20-1. PubMed ID: 7835804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):683-8. PubMed ID: 1506730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian cancer screening. The search for cost-effective methods.
    Williams L
    Postgrad Med; 1992 Dec; 92(8):63-6, 72. PubMed ID: 1454673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of CA 125 serum assay in the management of ovarian cancer. Commentary.
    Jacobs I; Oram D
    Br J Obstet Gynaecol; 1987 Aug; 94(8):819-21. PubMed ID: 3478081
    [No Abstract]   [Full Text] [Related]  

  • 25. Ovarian cancer screening.
    Mackey SE; Creasman WT
    J Clin Oncol; 1995 Mar; 13(3):783-93. PubMed ID: 7884436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian cancer screening.
    Sparks JM; Varner RE
    Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raised serum CA 125 preceding the diagnosis of carcinoma of the fallopian tube: two case reports.
    Davies AP; Fish A; Woolas R; Oram D
    Br J Obstet Gynaecol; 1991 Jun; 98(6):602-3. PubMed ID: 1873255
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography--study on size of ovary to select subjects requiring second screening].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1173-9. PubMed ID: 1453046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
    Jacobs I; Davies AP; Bridges J; Stabile I; Fay T; Lower A; Grudzinskas JG; Oram D
    BMJ; 1993 Apr; 306(6884):1030-4. PubMed ID: 8490497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CA-125 as a screening test for ovarian cancer.
    Gocze PM; Freeman DA
    JAMA; 1993 Jun 23-30; 269(24):3106-7. PubMed ID: 8505808
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mass-screening for ovarian cancer by transvaginal ultrasonography--study on ultrasonographic findings].
    Sato S; Sugo T; Maruyama H; Kunugi K; Saito Y; Hasuo Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1234-40. PubMed ID: 7844441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is screening for ovarian cancer worthwhile?
    Philip J
    J Med Screen; 1994 Oct; 1(4):206-7. PubMed ID: 8790519
    [No Abstract]   [Full Text] [Related]  

  • 33. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mass-screening for ovarian cancer].
    Sato S; Higuchi T; Yokoyama Y; Sakamoto T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():601-4. PubMed ID: 15535316
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for ovarian cancer: not worthwhile for most patients.
    Wong JG; Feussner JR
    N C Med J; 1993 Sep; 54(9):438-40. PubMed ID: 8232615
    [No Abstract]   [Full Text] [Related]  

  • 36. Ovarian cancer screening in asymptomatic postmenopausal women.
    DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
    Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is screening for ovarian cancer beneficial?].
    Andolf E
    Lakartidningen; 1992 Jan; 89(4):187-9. PubMed ID: 1734148
    [No Abstract]   [Full Text] [Related]  

  • 38. The identification of high risk and practical strategies for a population based randomized trial of ovarian cancer screening.
    Scott IV
    Dis Markers; 1991; 9(3-4):133-52. PubMed ID: 1813206
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mass-screening for ovarian cancer by transvaginal ultrasonography--study on tumor markers at the second screening].
    Sato S; Sugo T; Maruyama H; Saito Y; Hasuo Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1247-53. PubMed ID: 7844443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening transvaginal ultrasonography of postmenopausal women in a private office setting.
    Holbert TR
    Am J Obstet Gynecol; 1994 Jun; 170(6):1699-703; discussion 1703-4. PubMed ID: 8203429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.